Public Release: 

The New York Academy of Sciences to host a symposium on cognitive dysfunction in multiple sclerosis

Medical and scientific experts and noted patient advocates will discuss new diagnostic and treatment options for cognitive impairments caused by MS

New York Academy of Sciences

On June 21-23, 2011, the New York Academy of Sciences will bring together physicians, neurologists, clinical neuropsychologists, cellular and molecular biologists and patient advocates to discuss current challenges and potential solutions for improving diagnosis, treatment and management of the cognitive symptoms of MS.

This two-and-a-half day conference titled "Cognitive Dysfunction in Multiple Sclerosis: New Approaches to Diagnosis and Treatment" will include four sessions covering: I) how lesions in the brain are responsible for cognitive impairment in MS; II) novel drug therapies that may improve cognitive symptoms of the disease; III) new tests designed to diagnose cognitive impairment in patients; and IV) how brain imaging can help us better understand cognitive dysfunction in MS.

The conference will begin with a public lecture by Dr Aaron Miller of Mount Sinai Medical Center titled "State of the Science in Therapeutics for Multiple Sclerosis." This lecture will be followed by a panel discussion featuring patient advocates Cynthia Sitcov and Jeffrey Gingold, and Dr Nicholas LaRocca of the National Multiple Sclerosis Society. A reception and book signing will follow. Registration is required.

"The therapeutic advances have been remarkable since first learning I had MS in 1975. For anyone who lives with MS or knows someone who does, this lecture will provide an opportunity to learn about the newest treatments and get input from MS patient advocates," says Cynthia Sitcov, Patient's Representative, Central and Peripheral System Advisory Committee, US Food and Drug Administration.

Join the Academy for this special discussion of current challenges and potential solutions for improving diagnosis, treatment, and management of MS with a special focus on its effects on cognition.

To see the full agenda and list of esteemed speakers, visit http://bit.nyas.org/jJH0kK. Register today.

WHAT: A Symposium on 'Cognitive Dysfunction in Multiple Sclerosis'

WHEN: Tuesday-Thursday | Jun 21-23, 2011
5:00 PM - 5:00 PM

WHO: Medical and scientific experts on Multiple Sclerosis and patient advocates

WHERE: The New York Academy of Sciences
7 World Trade Center
250 Greenwich St., 40th Floor
New York, NY 10007

###

The New York Academy of Sciences is an independent, not-for-profit organization committed to advancing science, technology, and society worldwide since 1817. With 25,000 members in 140 countries, NYAS is creating a global community of science for the benefit of humanity. NYAS' core mission is to advance scientific knowledge, positively impact the major global challenges of society with science-based solutions, and increase the number of scientifically informed individuals in society at large. For more information, please visit www.nyas.org.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.